 | • レポートコード：MRC2-11QY14582 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は狂犬病治療のグローバル市場について調査・分析したレポートです。種類別（細胞培養ワクチン（CCV）、狂犬病免疫グロブリン（RIG）、神経組織ワクチン（NTV））市場規模、用途別（暴露前予防、暴露後予防）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別狂犬病治療の競争状況、市場シェア ・世界の狂犬病治療市場：種類別市場規模 2015年-2020年（細胞培養ワクチン（CCV）、狂犬病免疫グロブリン（RIG）、神経組織ワクチン（NTV）） ・世界の狂犬病治療市場：種類別市場規模予測 2021年-2026年（細胞培養ワクチン（CCV）、狂犬病免疫グロブリン（RIG）、神経組織ワクチン（NTV）） ・世界の狂犬病治療市場：用途別市場規模 2015年-2020年（暴露前予防、暴露後予防） ・世界の狂犬病治療市場：用途別市場規模予測 2021年-2026年（暴露前予防、暴露後予防） ・北米の狂犬病治療市場分析：米国、カナダ ・ヨーロッパの狂犬病治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの狂犬病治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の狂犬病治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの狂犬病治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Cadila Healthcare、GlaxoSmithKline、Merial、Sanofi、Merck、Pfizer、Bayer、AstraZeneca、Amneal Pharmaceuticals、Anergis ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Rabies Treatment Market
The global Rabies Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Rabies Treatment Scope and Market Size
Rabies Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rabies Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Rabies Treatment market is segmented into
Cell culture vaccines (CCVs)
Rabies immunoglobulin (RIGs)
Nerve tissue vaccines (NTVs)
Segment by Application, the Rabies Treatment market is segmented into
Pre-exposure prophylaxis
Post-exposure prophylaxis
Regional and Country-level Analysis
The Rabies Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Rabies Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Rabies Treatment Market Share Analysis
Rabies Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Rabies Treatment business, the date to enter into the Rabies Treatment market, Rabies Treatment product introduction, recent developments, etc.
The major vendors covered:
Cadila Healthcare
GlaxoSmithKline
Merial
Sanofi
Merck
Pfizer
Bayer
AstraZeneca
Amneal Pharmaceuticals
Anergis
1 Study Coverage
1.1 Rabies Treatment Product Introduction
1.2 Market Segments
1.3 Key Rabies Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Rabies Treatment Market Size Growth Rate by Type
1.4.2 Cell culture vaccines (CCVs)
1.4.3 Rabies immunoglobulin (RIGs)
1.4.4 Nerve tissue vaccines (NTVs)
1.5 Market by Application
1.5.1 Global Rabies Treatment Market Size Growth Rate by Application
1.5.2 Pre-exposure prophylaxis
1.5.3 Post-exposure prophylaxis
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Rabies Treatment Market Size, Estimates and Forecasts
2.1.1 Global Rabies Treatment Revenue 2015-2026
2.1.2 Global Rabies Treatment Sales 2015-2026
2.2 Global Rabies Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Rabies Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Rabies Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Rabies Treatment Competitor Landscape by Players
3.1 Rabies Treatment Sales by Manufacturers
3.1.1 Rabies Treatment Sales by Manufacturers (2015-2020)
3.1.2 Rabies Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Rabies Treatment Revenue by Manufacturers
3.2.1 Rabies Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Rabies Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Rabies Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Rabies Treatment Revenue in 2019
3.2.5 Global Rabies Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Rabies Treatment Price by Manufacturers
3.4 Rabies Treatment Manufacturing Base Distribution, Product Types
3.4.1 Rabies Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Rabies Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Rabies Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Rabies Treatment Market Size by Type (2015-2020)
4.1.1 Global Rabies Treatment Sales by Type (2015-2020)
4.1.2 Global Rabies Treatment Revenue by Type (2015-2020)
4.1.3 Rabies Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Rabies Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Rabies Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Rabies Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Rabies Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Rabies Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Rabies Treatment Market Size by Application (2015-2020)
5.1.1 Global Rabies Treatment Sales by Application (2015-2020)
5.1.2 Global Rabies Treatment Revenue by Application (2015-2020)
5.1.3 Rabies Treatment Price by Application (2015-2020)
5.2 Rabies Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Rabies Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Rabies Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Rabies Treatment Price Forecast by Application (2021-2026)
6 North America
6.1 North America Rabies Treatment by Country
6.1.1 North America Rabies Treatment Sales by Country
6.1.2 North America Rabies Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Rabies Treatment Market Facts & Figures by Type
6.3 North America Rabies Treatment Market Facts & Figures by Application
7 Europe
7.1 Europe Rabies Treatment by Country
7.1.1 Europe Rabies Treatment Sales by Country
7.1.2 Europe Rabies Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Rabies Treatment Market Facts & Figures by Type
7.3 Europe Rabies Treatment Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Rabies Treatment by Region
8.1.1 Asia Pacific Rabies Treatment Sales by Region
8.1.2 Asia Pacific Rabies Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Rabies Treatment Market Facts & Figures by Type
8.3 Asia Pacific Rabies Treatment Market Facts & Figures by Application
9 Latin America
9.1 Latin America Rabies Treatment by Country
9.1.1 Latin America Rabies Treatment Sales by Country
9.1.2 Latin America Rabies Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Rabies Treatment Market Facts & Figures by Type
9.3 Central & South America Rabies Treatment Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Rabies Treatment by Country
10.1.1 Middle East and Africa Rabies Treatment Sales by Country
10.1.2 Middle East and Africa Rabies Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Rabies Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Rabies Treatment Market Facts & Figures by Application
11 Company Profiles
11.1 Cadila Healthcare
11.1.1 Cadila Healthcare Corporation Information
11.1.2 Cadila Healthcare Description and Business Overview
11.1.3 Cadila Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cadila Healthcare Rabies Treatment Products Offered
11.1.5 Cadila Healthcare Related Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Description and Business Overview
11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline Rabies Treatment Products Offered
11.2.5 GlaxoSmithKline Related Developments
11.3 Merial
11.3.1 Merial Corporation Information
11.3.2 Merial Description and Business Overview
11.3.3 Merial Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merial Rabies Treatment Products Offered
11.3.5 Merial Related Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Description and Business Overview
11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi Rabies Treatment Products Offered
11.4.5 Sanofi Related Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Description and Business Overview
11.5.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Merck Rabies Treatment Products Offered
11.5.5 Merck Related Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Description and Business Overview
11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Rabies Treatment Products Offered
11.6.5 Pfizer Related Developments
11.7 Bayer
11.7.1 Bayer Corporation Information
11.7.2 Bayer Description and Business Overview
11.7.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bayer Rabies Treatment Products Offered
11.7.5 Bayer Related Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Description and Business Overview
11.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.8.4 AstraZeneca Rabies Treatment Products Offered
11.8.5 AstraZeneca Related Developments
11.9 Amneal Pharmaceuticals
11.9.1 Amneal Pharmaceuticals Corporation Information
11.9.2 Amneal Pharmaceuticals Description and Business Overview
11.9.3 Amneal Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Amneal Pharmaceuticals Rabies Treatment Products Offered
11.9.5 Amneal Pharmaceuticals Related Developments
11.10 Anergis
11.10.1 Anergis Corporation Information
11.10.2 Anergis Description and Business Overview
11.10.3 Anergis Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Anergis Rabies Treatment Products Offered
11.10.5 Anergis Related Developments
11.1 Cadila Healthcare
11.1.1 Cadila Healthcare Corporation Information
11.1.2 Cadila Healthcare Description and Business Overview
11.1.3 Cadila Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cadila Healthcare Rabies Treatment Products Offered
11.1.5 Cadila Healthcare Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Rabies Treatment Market Estimates and Projections by Region
12.1.1 Global Rabies Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Rabies Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Rabies Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Rabies Treatment Sales Forecast (2021-2026)
12.2.2 North America: Rabies Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Rabies Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Rabies Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Rabies Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Rabies Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Rabies Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Rabies Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Rabies Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Rabies Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Rabies Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Rabies Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Rabies Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Rabies Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Rabies Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Rabies Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Rabies Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Rabies Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Rabies Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Rabies Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Rabies Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Rabies Treatment Market Segments
Table 2. Ranking of Global Top Rabies Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Rabies Treatment Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Cell culture vaccines (CCVs)
Table 5. Major Manufacturers of Rabies immunoglobulin (RIGs)
Table 6. Major Manufacturers of Nerve tissue vaccines (NTVs)
Table 7. Global Rabies Treatment Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 8. Global Rabies Treatment Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 9. Global Rabies Treatment Sales by Regions 2015-2020 (K Pcs)
Table 10. Global Rabies Treatment Sales Market Share by Regions (2015-2020)
Table 11. Global Rabies Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Rabies Treatment Sales by Manufacturers (2015-2020) (K Pcs)
Table 13. Global Rabies Treatment Sales Share by Manufacturers (2015-2020)
Table 14. Global Rabies Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Rabies Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rabies Treatment as of 2019)
Table 16. Rabies Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Rabies Treatment Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Rabies Treatment Price (2015-2020) (USD/Pcs)
Table 19. Rabies Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Rabies Treatment Product Type
Table 21. Date of International Manufacturers Enter into Rabies Treatment Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Rabies Treatment Sales by Type (2015-2020) (K Pcs)
Table 24. Global Rabies Treatment Sales Share by Type (2015-2020)
Table 25. Global Rabies Treatment Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Rabies Treatment Revenue Share by Type (2015-2020)
Table 27. Rabies Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 28. Global Rabies Treatment Sales by Application (2015-2020) (K Pcs)
Table 29. Global Rabies Treatment Sales Share by Application (2015-2020)
Table 30. North America Rabies Treatment Sales by Country (2015-2020) (K Pcs)
Table 31. North America Rabies Treatment Sales Market Share by Country (2015-2020)
Table 32. North America Rabies Treatment Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Rabies Treatment Revenue Market Share by Country (2015-2020)
Table 34. North America Rabies Treatment Sales by Type (2015-2020) (K Pcs)
Table 35. North America Rabies Treatment Sales Market Share by Type (2015-2020)
Table 36. North America Rabies Treatment Sales by Application (2015-2020) (K Pcs)
Table 37. North America Rabies Treatment Sales Market Share by Application (2015-2020)
Table 38. Europe Rabies Treatment Sales by Country (2015-2020) (K Pcs)
Table 39. Europe Rabies Treatment Sales Market Share by Country (2015-2020)
Table 40. Europe Rabies Treatment Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Rabies Treatment Revenue Market Share by Country (2015-2020)
Table 42. Europe Rabies Treatment Sales by Type (2015-2020) (K Pcs)
Table 43. Europe Rabies Treatment Sales Market Share by Type (2015-2020)
Table 44. Europe Rabies Treatment Sales by Application (2015-2020) (K Pcs)
Table 45. Europe Rabies Treatment Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Rabies Treatment Sales by Region (2015-2020) (K Pcs)
Table 47. Asia Pacific Rabies Treatment Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Rabies Treatment Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Rabies Treatment Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Rabies Treatment Sales by Type (2015-2020) (K Pcs)
Table 51. Asia Pacific Rabies Treatment Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Rabies Treatment Sales by Application (2015-2020) (K Pcs)
Table 53. Asia Pacific Rabies Treatment Sales Market Share by Application (2015-2020)
Table 54. Latin America Rabies Treatment Sales by Country (2015-2020) (K Pcs)
Table 55. Latin America Rabies Treatment Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Rabies Treatment Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Rabies Treatment Revenue Market Share by Country (2015-2020)
Table 58. Latin America Rabies Treatment Sales by Type (2015-2020) (K Pcs)
Table 59. Latin America Rabies Treatment Sales Market Share by Type (2015-2020)
Table 60. Latin America Rabies Treatment Sales by Application (2015-2020) (K Pcs)
Table 61. Latin America Rabies Treatment Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Rabies Treatment Sales by Country (2015-2020) (K Pcs)
Table 63. Middle East and Africa Rabies Treatment Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Rabies Treatment Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Rabies Treatment Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Rabies Treatment Sales by Type (2015-2020) (K Pcs)
Table 67. Middle East and Africa Rabies Treatment Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Rabies Treatment Sales by Application (2015-2020) (K Pcs)
Table 69. Middle East and Africa Rabies Treatment Sales Market Share by Application (2015-2020)
Table 70. Cadila Healthcare Corporation Information
Table 71. Cadila Healthcare Description and Major Businesses
Table 72. Cadila Healthcare Rabies Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 73. Cadila Healthcare Product
Table 74. Cadila Healthcare Recent Development
Table 75. GlaxoSmithKline Corporation Information
Table 76. GlaxoSmithKline Description and Major Businesses
Table 77. GlaxoSmithKline Rabies Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. GlaxoSmithKline Product
Table 79. GlaxoSmithKline Recent Development
Table 80. Merial Corporation Information
Table 81. Merial Description and Major Businesses
Table 82. Merial Rabies Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Merial Product
Table 84. Merial Recent Development
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Major Businesses
Table 87. Sanofi Rabies Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Sanofi Product
Table 89. Sanofi Recent Development
Table 90. Merck Corporation Information
Table 91. Merck Description and Major Businesses
Table 92. Merck Rabies Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Merck Product
Table 94. Merck Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Major Businesses
Table 97. Pfizer Rabies Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Pfizer Product
Table 99. Pfizer Recent Development
Table 100. Bayer Corporation Information
Table 101. Bayer Description and Major Businesses
Table 102. Bayer Rabies Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Bayer Product
Table 104. Bayer Recent Development
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Major Businesses
Table 107. AstraZeneca Rabies Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. AstraZeneca Product
Table 109. AstraZeneca Recent Development
Table 110. Amneal Pharmaceuticals Corporation Information
Table 111. Amneal Pharmaceuticals Description and Major Businesses
Table 112. Amneal Pharmaceuticals Rabies Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. Amneal Pharmaceuticals Product
Table 114. Amneal Pharmaceuticals Recent Development
Table 115. Anergis Corporation Information
Table 116. Anergis Description and Major Businesses
Table 117. Anergis Rabies Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. Anergis Product
Table 119. Anergis Recent Development
Table 120. Global Rabies Treatment Sales Forecast by Regions (2021-2026) (K Pcs)
Table 121. Global Rabies Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 122. Global Rabies Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 123. Global Rabies Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 124. North America: Rabies Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 125. North America: Rabies Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Europe: Rabies Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 127. Europe: Rabies Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Asia Pacific: Rabies Treatment Sales Forecast by Region (2021-2026) (K Pcs)
Table 129. Asia Pacific: Rabies Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 130. Latin America: Rabies Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 131. Latin America: Rabies Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Middle East and Africa: Rabies Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 133. Middle East and Africa: Rabies Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key Rabies Treatment Players
Table 138. Rabies Treatment Customers List
Table 139. Rabies Treatment Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Rabies Treatment Product Picture
Figure 2. Global Rabies Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Cell culture vaccines (CCVs) Product Picture
Figure 4. Rabies immunoglobulin (RIGs) Product Picture
Figure 5. Nerve tissue vaccines (NTVs) Product Picture
Figure 6. Global Rabies Treatment Sales Market Share by Application in 2020 & 2026
Figure 7. Pre-exposure prophylaxis
Figure 8. Post-exposure prophylaxis
Figure 9. Rabies Treatment Report Years Considered
Figure 10. Global Rabies Treatment Market Size 2015-2026 (US$ Million)
Figure 11. Global Rabies Treatment Sales 2015-2026 (K Pcs)
Figure 12. Global Rabies Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Rabies Treatment Sales Market Share by Region (2015-2020)
Figure 14. Global Rabies Treatment Sales Market Share by Region in 2019
Figure 15. Global Rabies Treatment Revenue Market Share by Region (2015-2020)
Figure 16. Global Rabies Treatment Revenue Market Share by Region in 2019
Figure 17. Global Rabies Treatment Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Rabies Treatment Revenue in 2019
Figure 19. Rabies Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Rabies Treatment Sales Market Share by Type (2015-2020)
Figure 21. Global Rabies Treatment Sales Market Share by Type in 2019
Figure 22. Global Rabies Treatment Revenue Market Share by Type (2015-2020)
Figure 23. Global Rabies Treatment Revenue Market Share by Type in 2019
Figure 24. Global Rabies Treatment Market Share by Price Range (2015-2020)
Figure 25. Global Rabies Treatment Sales Market Share by Application (2015-2020)
Figure 26. Global Rabies Treatment Sales Market Share by Application in 2019
Figure 27. Global Rabies Treatment Revenue Market Share by Application (2015-2020)
Figure 28. Global Rabies Treatment Revenue Market Share by Application in 2019
Figure 29. North America Rabies Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 30. North America Rabies Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Rabies Treatment Sales Market Share by Country in 2019
Figure 32. North America Rabies Treatment Revenue Market Share by Country in 2019
Figure 33. U.S. Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 34. U.S. Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. Canada Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Rabies Treatment Market Share by Type in 2019
Figure 38. North America Rabies Treatment Market Share by Application in 2019
Figure 39. Europe Rabies Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 40. Europe Rabies Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Rabies Treatment Sales Market Share by Country in 2019
Figure 42. Europe Rabies Treatment Revenue Market Share by Country in 2019
Figure 43. Germany Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 44. Germany Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. France Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. U.K. Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Italy Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Russia Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Rabies Treatment Market Share by Type in 2019
Figure 54. Europe Rabies Treatment Market Share by Application in 2019
Figure 55. Asia Pacific Rabies Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 56. Asia Pacific Rabies Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Rabies Treatment Sales Market Share by Region in 2019
Figure 58. Asia Pacific Rabies Treatment Revenue Market Share by Region in 2019
Figure 59. China Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. China Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Japan Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. South Korea Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. India Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Australia Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Taiwan Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Indonesia Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Thailand Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Malaysia Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Philippines Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Vietnam Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Rabies Treatment Market Share by Type in 2019
Figure 82. Asia Pacific Rabies Treatment Market Share by Application in 2019
Figure 83. Latin America Rabies Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 84. Latin America Rabies Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Rabies Treatment Sales Market Share by Country in 2019
Figure 86. Latin America Rabies Treatment Revenue Market Share by Country in 2019
Figure 87. Mexico Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 88. Mexico Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Brazil Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Argentina Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Rabies Treatment Market Share by Type in 2019
Figure 94. Latin America Rabies Treatment Market Share by Application in 2019
Figure 95. Middle East and Africa Rabies Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 96. Middle East and Africa Rabies Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Rabies Treatment Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Rabies Treatment Revenue Market Share by Country in 2019
Figure 99. Turkey Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 100. Turkey Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Saudi Arabia Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Rabies Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. U.A.E Rabies Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Rabies Treatment Market Share by Type in 2019
Figure 106. Middle East and Africa Rabies Treatment Market Share by Application in 2019
Figure 107. North America Rabies Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 108. North America Rabies Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Rabies Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. Europe Rabies Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Rabies Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Asia Pacific Rabies Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Rabies Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Latin America Rabies Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Rabies Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Middle East and Africa Rabies Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
ヒト狂犬病ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Human Rabies Vaccine Market The global Human Rabies Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Rabies Vaccine Scope and Market Size Human Rabies Vaccine market is…- 人間用狂犬病ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Rabies Vaccine for Humans Market The global Rabies Vaccine for Humans market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Rabies Vaccine for Humans Scope and Market Size Rabies Vaccine …
- 人獣共通感染症治療の世界市場（～2026年） Zoonotic Disease is directly transmitted from animals to humans through media such as air (influenza) or through bites and saliva (rabies). Market Analysis and Insights: Global Zoonotic Disease Treatment Market The global Zoonotic Disease Treatment market size is projected to reach US$ XX million by…
- 尺骨神経治療の世界市場（～2026年） Ulnar nerve runs all the way form the shoulder to the little finger. This nerve manages the muscles that allow humans to make movements with the finger. As the ulnar nerve isn't protected by muscle or bones chance of damage to the nerve is common. Globally North America is a major market for ulnar n…
- グロボイド細胞白質ジストロフィー（GLD）治療の世界市場（～2026年） Market Analysis and Insights: Global Globoid Cell Leukodystrophy Treatment Market The global Globoid Cell Leukodystrophy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Globoid Cell Leukodystrophy Treatment S…